Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment
The combination of chronic heart failure and atrial fibrillation is considered one of the most prognostically unfavorable alliances among cardiovascular diseases. Now the need for new markers as potential targets for therapeutic intervention is being actively discussed. To date, active study of card...
Saved in:
| Main Authors: | Kuryata O.V., Muhammad Muhammad, Mytrokhina O.S. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2018-05-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://medpers.dsma.dp.ua/issues/2018/N2/26-34.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment.
by: O. V. Kuryata, et al.
Published: (2018-06-01) -
The level of Β-2-microglobulin, albuminuria in patients with chronic heart failure and atrial fibrillation depending on the functional state of the kidneys.
by: Muhammad Muhammad
Published: (2018-05-01) -
GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01) -
New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: A. A. Sokolova, et al.
Published: (2021-07-01) -
Markers of kidney injury, lipid metabolism, and carbonyl stress in patients with type 1 diabetes and different levels of albuminuria
by: M. A. Darenskaya, et al.
Published: (2022-07-01)